Preoperative preparation of patients with cardiomyopathies in non-cardiac surgery

Zeljko Bradić1, Branislava Ivanović, Dejan Marković

  • 1Center for Anesthesiology, Clinical Center of Serbia, Belgrade, Serbia.

Acta Chirurgica Iugoslavica
|September 2, 2011
PubMed

Insights

Cardiomyopathies, heart muscle disorders, increase risks for heart failure and arrhythmias during surgery. Comprehensive preoperative evaluation and optimized drug therapy are crucial for patient safety.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Internal Medicine

Background:

  • Cardiomyopathies are myocardial diseases characterized by structural and functional heart muscle disorders.
  • These conditions are distinct from coronary artery disease, hypertension, valvular disease, and congenital heart disease.
  • Key phenotypes include dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular cardiomyopathies.

Purpose of the Study:

  • To outline the perioperative risks associated with various cardiomyopathies.
  • To detail essential preoperative evaluation components for patients with cardiomyopathy.
  • To provide guidance on managing pharmacotherapy and surgical timing in this patient population.

Main Methods:

  • Review of existing literature and clinical guidelines on cardiomyopathy management.
  • Identification of specific risks (heart failure, arrhythmias) for different cardiomyopathy types.
  • Compilation of standard preoperative assessment protocols, including diagnostic tests and laboratory evaluations.

Main Results:

  • Patients with dilated and hypertrophic cardiomyopathy face increased risks of perioperative congestive heart failure.
  • Hypertrophic and arrhythmogenic right ventricular cardiomyopathy patients are more susceptible to perioperative arrhythmias.
  • Optimized drug therapy and delayed surgery (when feasible) are recommended for untreated or decompensated cardiomyopathy.

Conclusions:

  • A multidisciplinary approach involving anesthesiologists, cardiologists, and surgeons is vital for preoperative evaluation.
  • Thorough patient assessment and medical optimization are critical for mitigating perioperative complications in cardiomyopathy patients.
  • Timely intervention and management strategies are essential for improving surgical outcomes in individuals with heart muscle disorders.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...